LEAP-008 trial

keytruda lenvima lung cancer results, merck eisai lung cancer combo, keytruda lenvima leap-006 leap-008 trials, keytruda lenvima nsclc fda approval, keytruda lenvima lung cancer survival, keytruda lenvima lung cancer safety, keytruda lenvima lung cancer market

Keytruda-Lenvima combo fails to improve survival in two lung cancer trials

Anika Sharma

Merck and Eisai’s collaborative effort with Keytruda and Lenvima faces yet another setback in their quest to combat cancer. Despite ...